{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:56:53Z","timestamp":1781323013046,"version":"3.54.1"},"reference-count":11,"publisher":"Japanese Circulation Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,6,10]]},"DOI":"10.1253\/circrep.cr-26-0058","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:10:39Z","timestamp":1776723039000},"page":"915-916","source":"Crossref","is-referenced-by-count":0,"title":["Obesity as a Systemic Disease\u3000\u2015 Metabolic Benefits of Modest Weight Reduction in Specific Health Guidance-Eligible Individuals \u2015"],"prefix":"10.1253","volume":"8","author":[{"given":"Tomoya","family":"Hara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hotamisligil GS. Inflammation and metabolic disorders. <i>Nature<\/i> 2006; 444: 860\u2013867, doi:10.1038\/nature05485.","DOI":"10.1038\/nature05485"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. <i>Nat Rev Immunol<\/i> 2011; 11: 85\u201397, doi:10.1038\/nri2921.","DOI":"10.1038\/nri2921"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: Interaction of neurohumoral and renal mechanisms. <i>Circ Res<\/i> 2015; 116: 991\u20131006, doi:10.1161\/circresaha.116.305697.","DOI":"10.1161\/CIRCRESAHA.116.305697"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: A Scientific Statement from the American Heart Association. <i>Circulation<\/i> 2021; 143: e984\u2013e1010, doi:10.1161\/cir.0000000000000973.","DOI":"10.1161\/CIR.0000000000000973"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Nishikawa M, Suzuki Y, Ko T, Kaneko H, Okada A, Takeda N, et al. Association of weight loss with improvement in metabolic status among people eligible for the specific health guidance program. <i>Circ Rep<\/i> 2026; 8: 909\u2013914, doi:10.1253\/circrep.CR-25-0266.","DOI":"10.1253\/circrep.CR-25-0266"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Liu T, Shimizu Y, Ota H, Hayashi T, Luo H, Che Y, et al. Allogenic mitochondria and associated organelle complex treatment attenuates high-fat diet-induced adipose tissue remodeling. <i>Circ Rep<\/i> 2025; 7: 661\u2013669, doi:10.1253\/circrep.CR-25-0045.","DOI":"10.1253\/circrep.CR-25-0045"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Nishikawa K, Minamisawa M, Yoshie K, Suzuki S, Tanaka K, Okuma Y, et al. Clinical profile and prognosis of patients with acute decompensated heart failure who met the obesity-related eligibility for subcutaneous semaglutide: Findings from the CURE-HF Registry. <i>Circ Rep<\/i> 2025; 7: 463\u2013472, doi:10.1253\/circrep.CR-25-0041.","DOI":"10.1253\/circrep.CR-25-0041"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation<\/i> 2019; 140: e596\u2013e646, doi:10.1161\/cir.0000000000000678.","DOI":"10.1161\/CIR.0000000000000678"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Ogawa M, Ishihara K, Kanejima Y, Yoshida N, Kanaoka K, Sumita Y, et al. Body mass index affects hospital-associated disability and economic burden in elective cardiovascular surgery: JROAD\/JROAD-DPC database. <i>Circ J<\/i> 2025; 89: 1538\u20131546, doi:10.1253\/circj.CJ-24-0901.","DOI":"10.1253\/circj.CJ-24-0901"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Miyazaki A, Yoshinaga M, Ogata H, Ito Y, Aoki M, Kubo T, et al. An alternative approach to determining metabolic syndrome component cutoffs in children and adolescents using segmental regression analysis. <i>Circ Rep<\/i> 2024; 6: 118\u2013126, doi:10.1253\/circrep.CR-24-0007.","DOI":"10.1253\/circrep.CR-24-0007"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Powell LH, Berkley-Patton J, Drees BM, Karavolos K, Lohse B, Masters KS, et al. Lifestyle intervention for sustained remission of metabolic syndrome: A randomized clinical trial. <i>JAMA Intern Med<\/i> 2026; 186: 67\u201377, doi:10.1001\/jamainternmed.2025.5900.","DOI":"10.1001\/jamainternmed.2025.5900"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/6\/8_CR-26-0058\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:22:06Z","timestamp":1781320926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/6\/8_CR-26-0058\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0058","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"CR-26-0058"}}